Skip to main content
. 2023 Jul 31;11(3):191–203. doi: 10.14791/btrt.2023.0008

Table 1. Clinical information of glioma patients.

Patient Diagnosis Grade Age Sex IDH type 1p19q co-deletion MGMT methylation Ki-67 (%) Overall survival (month)
P1 Diffuse astrocytoma II 42 M Wild Negative Negative 4 40
P2 Diffuse astrocytoma II 34 M Wild Negative Negative 5 85+
P3 Diffuse astrocytoma II 27 F Wild Negative Negative 2 94+
P4 Anaplastic astrocytoma III 36 M Wild Negative Positive 10 25
P5 Anaplastic astrocytoma III 63 F Wild Negative Positive 8 31
P6 Anaplastic astrocytoma III 52 M Wild Negative Negative 62+ 31
P7 Glioblastoma IV 63 M Wild Negative Positive 30 9
P8 Glioblastoma IV 27 M Wild Negative Positive 30 16
P9 Glioblastoma IV 39 F Wild Negative Negative 20 32